Anti-D2-40, clone YN02036m

Anti-D2-40, clone YN02036m
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-PA6924.1.5 1500 µl - -

10 - 15 Werktage*

99,00 €
E-PA6924.3 3 ml - -

10 - 15 Werktage*

176,00 €
E-PA6924.6 6 ml - -

10 - 15 Werktage*

314,00 €
 
Carcinoembryonic antigen M2A (D2-40) is a 40kDa O-linked sialoglycoprotein that is a selective... mehr
Produktinformationen "Anti-D2-40, clone YN02036m"
Carcinoembryonic antigen M2A (D2-40) is a 40kDa O-linked sialoglycoprotein that is a selective marker of lymphatic endothelium in normal tissues and vascular lesions. D2-40 was expressed on the surface of spermatogenic cells, germ cell tumors, lymphatic endothelial cells and mesothelial cells in the testis, and on the surface of mesothelial cells and primordial germ cells. Studies have shown that D2-40 is stained in the lymphatic endothelium, but not in the adjacent capillaries. It is usually used to mark the lymphatic endothelium in tissues, which is helpful for the diagnosis of lymphatic endothelial cell tumors and the judgment of lymphatic invasion and metastasis in other tumor tissues. Protein function: Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed:14522983, PubMed:15231832, PubMed:17222411, PubMed:17616532, PubMed:18215137). Interaction with CD9, on the contrary, attenuates platelet aggregation induced by PDPN (PubMed:18541721). Through MSN or EZR interaction promotes epithelial- mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA activation leading to cell migration increase and invasiveness (PubMed:17046996, PubMed:21376833). Interaction with CD44 promotes directional cell migration in epithelial and tumor cells (PubMed:20962267). In lymph nodes (LNs), controls fibroblastic reticular cells (FRCs) adhesion to the extracellular matrix (ECM) and contraction of the actomyosin by maintaining ERM proteins (EZR, MSN and RDX) and MYL9 activation through association with unknown transmembrane proteins. Engagement of CLEC1B by PDPN promotes FRCs relaxation by blocking lateral membrane interactions leading to reduction of ERM proteins (EZR, MSN and RDX) and MYL9 activation. Through binding with LGALS8 may participate in connection of the lymphatic endothelium to the surrounding extracellular matrix (PubMed:19268462). In keratinocytes, induces changes in cell morphology showing an elongated shape, numerous membrane protrusions, major reorganization of the actin cytoskeleton, increased motility and decreased cell adhesion (PubMed:15515019). Controls invadopodia stability and maturation leading to efficient degradation of the extracellular matrix (ECM) in tumor cells through modulation of RHOC activity in order to activate ROCK1/ROCK2 and LIMK1/LIMK2 and inactivation of CFL1 (PubMed:25486435). Required for normal lung cell proliferation and alveolus formation at birth. Does not function as a water channel or as a regulator of aquaporin-type water channels (PubMed:9651190). Does not have any effect on folic acid or amino acid transport. [The UniProt Consortium]
Schlagworte: Anti-PSEC0003, D2-40 Monoclonal Antibody
Hersteller: Elabscience
Hersteller-Nr: E-PA6924

Eigenschaften

Anwendung: IHC-P
Antikörper-Typ: Monoclonal
Klon: YN02036m
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-D2-40, clone YN02036m"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen